X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Merck Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs MERCK LTD - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS MERCK LTD J.B.CHEMICALS/
MERCK LTD
 
P/E (TTM) x 17.0 45.5 37.3% View Chart
P/BV x 2.3 6.9 33.4% View Chart
Dividend Yield % 0.2 0.4 41.0%  

Financials

 J.B.CHEMICALS   MERCK LTD
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
MERCK LTD
Dec-16
J.B.CHEMICALS/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs3181,060 30.0%   
Low Rs200623 32.0%   
Sales per share (Unadj.) Rs148.0632.4 23.4%  
Earnings per share (Unadj.) Rs19.145.7 41.7%  
Cash flow per share (Unadj.) Rs23.962.3 38.4%  
Dividends per share (Unadj.) Rs0.5011.00 4.5%  
Dividend yield (eoy) %0.21.3 14.8%  
Book value per share (Unadj.) Rs128.9388.8 33.2%  
Shares outstanding (eoy) m84.8216.60 511.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.71.3 131.4%   
Avg P/E ratio x13.618.4 73.7%  
P/CF ratio (eoy) x10.813.5 80.0%  
Price / Book Value ratio x2.02.2 92.7%  
Dividend payout %2.624.1 10.9%   
Avg Mkt Cap Rs m21,95113,969 157.1%   
No. of employees `0002.71.6 172.7%   
Total wages/salary Rs m1,8411,487 123.8%   
Avg. sales/employee Rs Th4,590.96,631.9 69.2%   
Avg. wages/employee Rs Th673.4939.2 71.7%   
Avg. net profit/employee Rs Th592.1479.4 123.5%   
INCOME DATA
Net Sales Rs m12,55110,498 119.6%  
Other income Rs m542242 223.4%   
Total revenues Rs m13,09310,741 121.9%   
Gross profit Rs m2,0551,135 181.0%  
Depreciation Rs m412276 149.7%   
Interest Rs m960-   
Profit before tax Rs m2,0881,102 189.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m469343 136.6%   
Profit after tax Rs m1,619759 213.3%  
Gross profit margin %16.410.8 151.4%  
Effective tax rate %22.531.1 72.1%   
Net profit margin %12.97.2 178.4%  
BALANCE SHEET DATA
Current assets Rs m7,7786,410 121.3%   
Current liabilities Rs m4,3588,828 49.4%   
Net working cap to sales %27.2-23.0 -118.3%  
Current ratio x1.80.7 245.8%  
Inventory Days Days5558 94.8%  
Debtors Days Days8038 208.5%  
Net fixed assets Rs m5,7131,406 406.2%   
Share capital Rs m170166 102.2%   
"Free" reserves Rs m10,5476,286 167.8%   
Net worth Rs m10,9376,455 169.4%   
Long term debt Rs m00-   
Total assets Rs m15,5748,828 176.4%  
Interest coverage x22.8NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.81.2 67.8%   
Return on assets %11.08.6 128.1%  
Return on equity %14.811.8 125.9%  
Return on capital %20.017.1 116.9%  
Exports to sales %48.78.3 588.3%   
Imports to sales %7.121.0 33.6%   
Exports (fob) Rs m6,115869 703.3%   
Imports (cif) Rs m8892,209 40.2%   
Fx inflow Rs m6,169959 643.4%   
Fx outflow Rs m1,2852,612 49.2%   
Net fx Rs m4,884-1,653 -295.4%   
CASH FLOW
From Operations Rs m1,3971,070 130.5%  
From Investments Rs m-320-750 42.7%  
From Financial Activity Rs m-1,196-150 798.3%  
Net Cashflow Rs m-102171 -59.9%  

Share Holding

Indian Promoters % 55.4 0.0 -  
Foreign collaborators % 0.3 51.8 0.6%  
Indian inst/Mut Fund % 3.4 18.2 18.6%  
FIIs % 3.9 1.0 390.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 29.1 127.1%  
Shareholders   30,437 28,591 106.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   STRIDES SHASUN LTD  AJANTA PHARMA  SUVEN LIFE  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Marginally Lower; FMCG & IT Stocks Witness Losses(Closing)

After opening the day on a positive note today, Indian share markets witnessed losses thereafter and ended their trading session marginally lower.

Related Views on News

MERCK LTD Announces Quarterly Results (1QFY19); Net Profit Up 63.1% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, MERCK LTD has posted a net profit of Rs 328 m (up 63.1% YoY). Sales on the other hand came in at Rs 2 bn (down 17.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (4QFY18); Net Profit Up 53.2% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, MERCK LTD has posted a net profit of Rs 227 m (up 53.2% YoY). Sales on the other hand came in at Rs 3 bn (up 27.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Oh Yes! This is the Best Trading Opportunity in Two Decades(Profit Hunter)

Sep 21, 2018

Getting ready to buy stocks once this correction is over? This private sector bank should be on a profit hunter's radar.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

How IL&FS Rating Downgrade Will Impact Your Mutual Funds...(Outside View)

Sep 17, 2018

PersonalFN explains the impact of IL&FS rating downgrade on mutual funds.

How To Identify Sachin Tendulkars And Rahul Dravids Of Tomorrow For Your Mutual Fund Portfolio(Outside View)

Sep 19, 2018

PersonalFN explains how to pick 'undiscovered' or lesser-known mutual funds that are capable of generating big gains for you.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Sep 26, 2018 03:37 PM

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - MERCK LTD COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS